1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Fibromyalgia patients with elevated levels of anti–satellite glia cell immunoglobulin G antibodies present with more severe symptoms 2023 Krock et al

Discussion in ''Conditions related to ME/CFS' news and research' started by Andy, Mar 22, 2023.

  1. Andy

    Andy Committee Member

    Messages:
    21,962
    Location:
    Hampshire, UK
    Transferring fibromyalgia patient immunoglobulin G (IgG) to mice induces pain-like behaviour, and fibromyalgia IgG binds mouse and human satellite glia cells (SGCs). These findings suggest that autoantibodies could be part of fibromyalgia pathology. However, it is unknown how frequently fibromyalgia patients have anti-SGC antibodies and how anti-SGC antibodies associate with disease severity.

    Here, we quantified serum or plasma anti-SGC IgG levels in 2 fibromyalgia cohorts from Sweden and Canada using an indirect immunofluorescence murine cell culture assay. Fibromyalgia serum IgG binding to human SGCs in human dorsal root ganglia tissue sections was also assessed by immunofluorescence. In the cell culture assay, anti-SGC IgG levels were increased in both fibromyalgia cohorts compared with control group. Elevated anti-SGC IgG was associated with higher levels of self-reported pain in both cohorts, and higher fibromyalgia impact questionnaire scores and increased pressure sensitivity in the Swedish cohort. Anti-SGC IgG levels were not associated with fibromyalgia duration. Swedish fibromyalgia (FM) patients were clustered into FM-severe and FM-mild groups, and the FM-severe group had elevated anti-SGC IgG compared with the FM-mild group and control group. Anti-SGC IgG levels detected in culture positively correlated with increased binding to human SGCs. Moreover, the FM-severe group had elevated IgG binding to human SGCs compared with the FM-mild and control groups.

    These results demonstrate that a subset of fibromyalgia patients have elevated levels of anti-SGC antibodies, and the antibodies are associated with more severe fibromyalgia symptoms. Screening fibromyalgia patients for anti-SGC antibodies could provide a path to personalized treatment options that target autoantibodies and autoantibody production.

    Open access, https://journals.lww.com/pain/Fulltext/9900/Fibromyalgia_patients_with_elevated_levels_of.274.aspx
     
  2. Grigor

    Grigor Senior Member (Voting Rights)

    Messages:
    544
    Interesting study building on the findings by Goebel.
     
  3. Aspen

    Aspen Established Member

    Messages:
    4
    @Jonathan Edwards, hoping you can respond to this. Same issues as what you stated in the Goebel thread?
     
    shak8 and Peter Trewhitt like this.
  4. voner

    voner Senior Member (Voting Rights)

    Messages:
    222
    here is a quote from near the end of the the paper assesing the use of pooled IgG in the previous paper:

     
    RedFox, alktipping, Grigor and 2 others like this.
  5. Andy

    Andy Committee Member

    Messages:
    21,962
    Location:
    Hampshire, UK

Share This Page